| Gene symbol | TACSTD2 | Synonyms | EGP-1, EGP1, GA733-1, GA7331, GP50, M1S1, TROP2 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p32.1 | dbXrefs | |
| Description | tumor associated calcium signal transducer 2 | ||||
| GTO ID | GTC3490 |
| Trial ID | NCT05922930 |
| Disease | Pancreatic Cancer | Ovarian Cancer | Adenocarcinoma |
| Altered gene | TROP2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | TROP2 CAR-NK cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer |
| Year | 2023 |
| Country | United States |
| Company sponsor | M.D. Anderson Cancer Center |
| Other ID(s) | 2022-0687|NCI-2023-05027 |
| Cohort 1 | |||||||||
|
|||||||||